Press Releases from DelveInsight Business Research LLP (4751 total)
Adult Growth Hormone Deficiency (AGHD) Market to Observe Impressive Growth Durin …
As per DelveInsight, the Adult Growth Hormone Deficiency (AGHD) Market is anticipated to evolve immensely in the coming years owing to the extensive R&D activities…
Pancreatic Cancer Market is Expected to Showcase a Significant Growth During the …
As per DelveInsight, the Pancreatic Cancer Market is anticipated to evolve immensely in the coming years owing to the rising incidence, increasing global healthcare investment…
Retinitis Pigmentosa Market to Register Stunning Growth During the Forecast Peri …
As per DelveInsight, the Retinitis Pigmentosa Market is anticipated to evolve immensely in the coming years owing to the expected launch of potential therapies, along…
Irritable Bowel Syndrome Pipeline Assessment (2023 Updates) | In-depth Insights …
As per DelveInsight's assessment, globally, about 24+ key pharma and biotech companies are working on 24+ pipeline drugs in the Irritable Bowel Syndrome (IBS) therapeutics…
Metastatic Prostate Cancer Pipeline Assessment (2023 Updates) | In-depth Insight …
As per DelveInsight's assessment, globally, about 90+ key pharma and biotech companies are working on 110+ pipeline drugs in the Metastatic Prostate Cancer therapeutics landscape…
Primary Biliary Cirrhosis Pipeline Assessment (2023 Updates) | In-depth Insights …
As per DelveInsight's assessment, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Primary Biliary Cirrhosis therapeutics landscape based…
Heart Failure Pipeline Assessment (2023 Updates) | In-depth Insights into the Cl …
As per DelveInsight's assessment, globally, about 75+ key pharma and biotech companies are working on 90+ pipeline drugs in the Heart Failure therapeutics landscape based…
Psoriatic Arthritis Pipeline Assessment (2023 Updates) | In-depth Insights into …
As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Psoriatic Arthritis therapeutics landscape based…
Renal Anemia Pipeline Assessment (2023 Updates) | In-depth Insights into the Cli …
As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Renal Anemia therapeutics landscape based…
Non-Alcoholic Fatty Liver Disease (NAFLD) Pipeline Assessment (2023 Updates) | I …
As per DelveInsight's assessment, globally, about 110+ key pharma and biotech companies are working on 160+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease (NAFLD)…
Non-Alcoholic Fatty Liver Disease (NAFLD) Pipeline Assessment (2023 Updates) | I …
As per DelveInsight's assessment, globally, about 110+ key pharma and biotech companies are working on 160+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease (NAFLD)…
Cancer Therapy Related Diarrhea Pipeline Assessment (2023 Updates) | In-depth In …
"Cancer Therapy Related Diarrhea Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the…
Dry Eye Disease Pipeline Assessment (2023 Updates) | In-depth Insights into the …
As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Dry Eye Disease therapeutics landscape…
Duchenne Muscular Dystrophy Pipeline Assessment (2023 Updates) | In-depth Insigh …
As per DelveInsight's assessment, globally, about 75+ key pharma and biotech companies are working on 75+ pipeline drugs in the Duchenne Muscular Dystrophy therapeutics landscape…
Retinitis Pigmentosa Pipeline Assessment (2023 Updates) | In-depth Insights into …
As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 30+ pipeline drugs in the Retinitis Pigmentosa therapeutics landscape based…
Ulcerative Colitis Pipeline Assessment (2023 Updates) | In-depth Insights into t …
As per DelveInsight's assessment, globally, about 110+ key pharma and biotech companies are working on 110+ pipeline drugs in the Ulcerative Colitis therapeutics landscape based…
Alzheimer's Disease Pipeline Assessment (2023 Updates) | In-depth Insights into …
As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 100+ pipeline drugs in the Alzheimer's Disease therapeutics landscape based…
Spinocerebellar Ataxias Market to Register Incremental Growth During the Forecas …
As per DelveInsight, the Spinocerebellar Ataxias Market is anticipated to evolve immensely in the coming years owing to the increase in the prevalent population of…
Ewing Sarcoma Market to Register Immense Growth During the Forecast Period (2022 …
As per DelveInsight, the Ewing Sarcoma Market is anticipated to evolve immensely in the coming years owing to the improvement in the diagnosis methodologies, incremental…
Coronary Artery Disease Pipeline Assessment (2023 Updates) | In-depth Insights i …
As per DelveInsight's assessment, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Coronary Artery Disease therapeutics landscape based…
Brain Metastases Pipeline Assessment (2023 Updates) | In-depth Insights into the …
As per DelveInsight's assessment, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Brain Metastases therapeutics landscape based on…
Renal Cell Carcinoma Pipeline Assessment (2023 Updates) | In-depth Insights into …
As per DelveInsight's assessment, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Renal Cell Carcinoma therapeutics landscape based…
Prostate Cancer Pipeline Assessment (2023 Updates) | In-depth Insights into the …
As per DelveInsight's assessment, about 200+ key pharma and biotech companies are working on 200+ pipeline drugs in the Prostate Cancer therapeutics landscape based on…
Hepatocellular Carcinoma Pipeline Assessment (2023 Updates) | In-depth Insights …
As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Hepatocellular Carcinoma therapeutics landscape based…
Prosthetic Joint Infection (PJI) Market to Observe Stunning Growth During the Fo …
As per DelveInsight, the Prosthetic Joint Infection Market size was found to be USD 57.73 million in 2017, which is expected to grow by 2032.…
Alcoholic Hepatitis Emerging and Marketed Drugs Assessment (2023 Updates) | Clin …
As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Alcoholic Hepatitis therapeutics landscape based…
Von Willebrand Disease Emerging and Marketed Drugs Assessment (2023 Updates) | C …
As per DelveInsight's assessment, globally, several major key pharma and biotech companies are actively working in the Von Willebrand Disease therapeutics landscape based on different…
Human Papillomavirus (HPV) Market to Observe Stupendous Growth During the Foreca …
As per DelveInsight, the Human Papillomavirus (HPV) Market is anticipated to evolve immensely in the coming years owing to the launch of upcoming therapies, the…
Systemic Lupus Erythematosus (SLE) Market to Register Incremental Growth During …
As per DelveInsight, the Systemic Lupus Erythematosus Market is anticipated to evolve immensely in the coming years owing to the expected launch of emerging therapies…
Recessive Dystrophic Epidermolysis Emerging and Marketed Drugs Assessment (2023 …
As per DelveInsight's assessment, globally, about 7+ key pharma and biotech companies are working on 7+ pipeline drugs in the Recessive Dystrophic Epidermolysis therapeutics landscape…
Becker Muscular Dystrophy Emerging and Marketed Drugs Assessment (2023 Updates) …
As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 8+ pipeline drugs in the Becker Muscular Dystrophy therapeutics landscape…
Cone Rod Dystrophy Emerging and Marketed Drugs Assessment (2023 Updates) | Clini …
The Cone Rod Dystrophy therapeutics market is anticipated to evolve immensely in the coming years owing to the increasing prevalent population of Cone rod dystrophies…
Chronic Lymphocytic Leukemia Emerging and Marketed Drugs Assessment (2023 Update …
As per DelveInsight's assessment, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Chronic Lymphocytic Leukemia therapeutics landscape based…
Epidermolysis Bullosa Emerging and Marketed Drugs Assessment (2023 Updates) | Cl …
As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in the Epidermolysis Bullosa therapeutics landscape…
MELAS Syndrome Market is Predicted to Exhibit Remarkable Growth During the Forec …
As per DelveInsight, the MELAS Syndrome Market is anticipated to evolve immensely in the coming years owing to the increase in the prevalence of MELAS…
Homozygous Familial Hypercholesterolemia (HoFH) Market to Observe Stupendous Gro …
As per DelveInsight, the Homozygous Familial Hypercholesterolemia Market is expected to grow in the coming years owing to the rise in the number of prevalent…
Duchenne Muscular Dystrophy (DMD) Market to Register Incremental Growth During t …
As per DelveInsight, the Duchenne Muscular Dystrophy Market is anticipated to evolve immensely in the coming years owing to the increase in the diagnosed prevalent…
Pseudomonal Infections Emerging and Marketed Drugs Assessment (2023 Updates) | C …
As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Pseudomonal Infections therapeutics landscape based…
Primary Sclerosing Cholangitis Emerging and Marketed Drugs Assessment (2023 Upda …
As per DelveInsight's assessment, globally, about 14+ key pharma and biotech companies are working on 14+ pipeline drugs in the Primary Sclerosing Cholangitis therapeutics landscape…
Fragile X Syndrome Emerging and Marketed Drugs Assessment (2023 Updates) | Clini …
As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 22+ pipeline drugs in the Fragile X Syndrome therapeutics landscape based…
Thyroid Cancer Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical …
As per DelveInsight's assessment, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Thyroid Cancer therapeutics landscape based on…
IPSC derived NK Cells Emerging and Marketed Drugs Assessment (2023 Updates) | Cl …
As per DelveInsight's assessment, about 15+ prominent pharma and biotech giants are working on 30+ drugs in the IPSC derived NK Cells pipeline landscape globally.
"IPSC…
Genital Herpes Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical …
As per DelveInsight's assessment, about 26+ key pharma and biotech companies are working on 28+ pipeline drugs in the Genital Herpes therapeutics landscape based on…
Pancreatic Cancer Emerging and Marketed Drugs Assessment (2023 Updates) | Clinic …
As per DelveInsight's assessment, globally, about 120+ key pharma and biotech companies are working on 150+ pipeline drugs in the Pancreatic Cancer therapeutics landscape based…
Cryopyrin-Associated Periodic Syndrome (CAPS) Market to Exhibit Substantial Grow …
As per DelveInsight, the Cryopyrin-Associated Periodic Syndrome therapeutics market is anticipated to grow immensely in the coming years owing to the expected improvement in the…
Collagen Inhibitors Pipeline Development Activities | Insights Into the Clinical …
As per DelveInsight's assessment, about 10+ prominent pharma and biotech giants are working on 10+ drugs in the Collagen Inhibitors pipeline landscape globally.
"Collagen Inhibitors Pipeline…
Transforming Growth Factor Beta (TGFb) Inhibitor Pipeline Development Activities …
As per DelveInsight's assessment, about 90+ prominent pharma and biotech giants are working on 90+ drugs in the Transforming Growth Factor Beta (TGFb) Inhibitor pipeline…
Shingles Emerging and Marketed Drugs Assessment (2023 Updates) | Clinical and No …
"Shingles Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Shingles Therapeutics Market.…
Severe Hypoglycemia Emerging and Marketed Drugs Assessment (2023 Updates) | Clin …
As per DelveInsight's assessment, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Severe Hypoglycemia therapeutics landscape based on…
Uncomplicated Urinary Tract Infections Emerging and Marketed Drugs Assessment (2 …
"Uncomplicated Urinary Tract Infections Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the…
